Safety and tolerability of the inhaled phosphodiesterase 4 inhibitor GSK256066 in moderate COPD.

H. Watz,Sunil J Mistry,A. Lazaar
DOI: https://doi.org/10.1016/j.pupt.2013.05.004
IF: 3.282
2013-10-01
Pulmonary Pharmacology & Therapeutics
Abstract:
What problem does this paper attempt to address?